4//SEC Filing
Fairley Ricki Louise 4
Accession 0001867096-23-000050
CIK 0001867096other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:53 PM ET
Size
4.9 KB
Accession
0001867096-23-000050
Insider Transaction Report
Form 4
Fairley Ricki Louise
Director
Transactions
- Award
Common Stock
2023-03-27+85,000→ 85,000 total
Footnotes (1)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001971350
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 4:53 PM ET
- Size
- 4.9 KB